Skip to main content
. 2018 Jun 26;17:1533033818782793. doi: 10.1177/1533033818782793

Table 5.

Comparison of Genotype and Allele Frequency of 5 Loci Between Patients With CIS and IC.

SNP Locus Group N Genotype Frequency (%) χ2/P a Allele Frequency (%) χ2/P b
CC/GG CT/GA TT/AA C/G T/A
rs361525 Carcinoma in situ 104 97 (93.3) 7 (6.7) 0 (0.0) χ2 = 2.356/P = .1248 201 (96.6) 7 (3.4) χ2 = 2.225/P = .1358
Invasive cancer 348 306 (87.9) 42 (12.1) 0 (0.0) 654 (94.0) 42 (6.0)
rs1800629 Carcinoma in situ 104 76 (73.1) 28 (26.9) 0 (0.0) χ2 = 0.558/P = .4552 180 (86.5) 28 (13.5) χ2 = 9.474/P = .002
Invasive cancer 348 241 (69.3) 107 (30.7) 0 (0.0) 589 (93.3) 42 (6.7)
rs1800750 Carcinoma in situ 104 104 (100.0) 0 (0.0) 0 (0.0) χ2 = 1.203/P = .2726 208 (100.0) 0 (0.0) P = .5790c
Invasive cancer 348 344 (98.9) 4 (1.1) 0 (0.0) 692 (99.4) 4 (0.6)
rs1799964 Carcinoma in situ 104 66 (64.3) 37 (35.6) 1 (0.01) χ2 = 0.414/P = .8117 171 (81.4) 39 (18.6) χ = 0.279/P = .5971
Invasive cancer 348 209 (60.0) 136 (39.1) 3 (0.9) 692 (83.0) 142 (17.0)
rs673 Carcinoma in situ 104 101 (97.1) 3 (2.9) 0 (0.0) χ2 = 028/P = .8682 205 (98.6) 3 (1.4) χ2 = 0.000/P = 1.000d
Invasive cancer 348 339 (98.9) 9 (1.1) 0 (0.0) 692 (98.7) 9 (1.3)

Abbreviations: CIS, carcinoma in situ; IC, invasive carcinoma; SNP, single nucleotide polymorphisms.

a Using Cochran-Mantel-Haenszel (CMH) test.

b Using χ2 test.

c Using Fisher test.

d Use continuity correction card.